EDGAR Filing Documents for 0001437749-17-015526

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001437749-17-015526

Filing Date

2017-09-01

Accepted

2017-09-01 16:45:13

Documents

Period of Report

2017-06-30

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-K	avir20170630_10k.htm	10-K	1332108
2	EXHIBIT 21.1	ex21-1.htm	EX-21.1	2777
3	EXHIBIT 23.1	ex23-1.htm	EX-23.1	8198
4	EXHIBIT 31.1	ex31-1.htm	EX-31.1	10083
5	EXHIBIT 31.2	ex31-2.htm	EX-31.2	9978
6	EXHIBIT 32.1	ex32-1.htm	EX-32.1	4763
7	EXHIBIT 32.2	ex32-2.htm	EX-32.2	5356
14		image.jpg	GRAPHIC	58269
	Complete submission text file	0001437749-17-015526.txt		5748938

Data Files

Seq	Description	Document	Type	Size
8	XBRL INSTANCE DOCUMENT	avir-20170630.xml	EX-101.INS	1137115
9	XBRL TAXONOMY EXTENSION SCHEMA	avir-20170630.xsd	EX-101.SCH	56476
10	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE	avir-20170630_cal.xml	EX-101.CAL	52527
11	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	avir-20170630_def.xml	EX-101.DEF	362659
12	XBRL TAXONOMY EXTENSION LABEL LINKBASE	avir-20170630_lab.xml	EX-101.LAB	313212
13	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	avir-20170630_pre.xml	EX-101.PRE	394547

Mailing Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009

Business Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009 301-770-3099

Aviragen Therapeutics, Inc. (Filer) CIK: 0000072444 (see all company filings)